 2, 136.3, 129.3, 128.8, 127.2, 68.2, 67.8, 45.8, 36.7, 36.3, 32.0, 31.8, 29.6-29.5 (br, 7C), 29.3, 25.5, 22.6, 14.1; IR (film): 3427, 2924 IR (film): 3427, , 2853 IR (film): 3427, , 1695 IR (film): 3427, , 1455 IR (film): 3427, , 1363 IR (film): 3427, , 1343 IR (film): 3427, , 1292 IR (film): 3427, , 1262 IR (film): 3427, , 1192 IR (film): 3427, , 1164 IR (film): 3427, , 1138 IR (film): 3427, , 1044 4, 173.8, 136.3, 129.4, 128.9, 127.2, 68.4, 68.2, 45.5, 36.7, 36.6, 32.0, 31.9, 29.6-29.5 (br, 7C), 29.3, 25.4, 22.6, 14.1; IR (film): 3427, 2924 IR (film): 3427, , 2853 IR (film): 3427, , 1699 IR (film): 3427, , 1683 IR (film): 3427, , 1496 IR (film): 3427, , 1467 IR (film): 3427, , 1455 IR (film): 3427, , 1343 IR (film): 3427, , 1294 IR (film): 3427, , 1262 IR (film): 3427, , 1164 IR (film): 3427, , 1138 IR (film): 3427, , 1040 
(R)-3-((tert-butyldimethylsilyl)oxy)-N-methoxy-N-methylhexadecanamide (9)
At 0°C, to a solution of compound 8 (87 mg, 0.28 mmol, 1.0 equiv.) and imidazole (75 mg, 1.10 mmol, 4.0 equiv.) in anhydrous DCM (1.7 mL) was added slowly the solution of TBSCl (95mg, 0.63mmol, 2.3equiv) in DCM. The mixture was then stirred overnight at room temperature. When TLC monitor indicated compound 8 was consumed, the reaction was quenched with sat. 5, 61.2, 39.6, 37.9, 31.9, 29.7-29.6 (br, 7C), 29.3, 25.8, 25.0, 22.6, 18.0, 14.0, -4.7, -4.7; IR (film): 2927 IR (film): , 2855 IR (film): , 2360 IR (film): , 1676 IR (film): , 1462 IR (film): , 1388 IR (film): , 1256 IR (film): , 1096 IR (film): , 1005 68.1, 41.0, 36.6, 31.9, 29.70-29.50 (br, 7C), 29.3, 25.4, 22.7, 14.1; IR (film): 2913 IR (film): , 2847 IR (film): , 1681 IR (film): , 1470 IR (film): , 1411 IR (film): , 1392 IR (film): , 1223 IR (film): , 1074 IR (film): , 1018 
